Click on image to view larger version.

Figure 2 Unadjusted and risk-adjusted in-hospital mortality for patients with non–ST-elevation myocardial infarction (NSTEMI), by the proportion of NSTEMI patients at each hospital treated early with a glycoprotein (GP) IIb/IIIa inhibitor.